2
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Treatment of basal cell carcinomas with intralesional recombinant interferonα-2b

&
Pages 15-16 | Published online: 12 Jul 2009
 

Abstract

Each of 21 patients with histologically proven basal cell carcinomas received three injections of 1.5 106 U recombinant interferona-2b per week for 3 weeks. Excision biopsies were performed 3 months after completion of treatment. Eight out of 19 biopsies revealed no evidence of residual tumour and 12 out of 20 patients experienced some side-effects considered mild by both patient and investigator in most cases.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.